Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
Cardiovascular risk is poorly managed in women, especially during the menopausal transition when susceptibility to cardiovascular events increases. Clear gender differences exist in the epidemiology, symptoms, diagnosis, progression, prognosis, and management of cardiovascular risk. Key risk factors that need to be controlled in the peri-menopausal woman are hypertension, dyslipidaemia, obesity, and other components of the metabolic syndrome, with the avoidance and careful control of diabetes. Hypertension is a particularly powerful risk factor and lowering of blood pressure is pivotal. Hormone replacement therapy is acknowledged as the gold standard for the alleviation of the distressing vasomotor symptoms of the menopause, but the findings of the Women's Health Initiative (WHI) study generated concern for the detrimental effect on cardiovascular events. Thus, hormone replacement therapy cannot be recommended for the prevention of cardiovascular disease. Whether the findings of WHI in older post-menopausal women can be applied to younger peri-menopausal women is unknown. It is increasingly recognized that hormone therapy is inappropriate for older post-menopausal women no longer displaying menopausal symptoms. Both gynaecologists and cardiovascular physicians have an important role to play in identifying peri-menopausal women at risk of cardiovascular morbidity and mortality and should work as a team to identify and manage risk factors such as hypertension.
Collins
Peter
P
NHLI, Imperial College London, Royal Brompton Hospital, Dovehouse Street, London SW3 6LY, UK. peter.collins@imperial.ac.uk
Rosano
Guiseppe
G
Casey
Catherine
C
Daly
Caroline
C
Gambacciani
Marco
M
Hadji
Peyman
P
Kaaja
Risto
R
Mikkola
Tomi
T
Palacios
Santiago
S
Preston
Richard
R
Simon
Tabassome
T
Stevenson
John
J
Stramba-Badiale
Marco
M
D002318:Cardiovascular Diseases / Q000628:therapy*; D003276:Contraceptives, Oral / Q000009:adverse effects; D048909:Diabetes Complications; D050171:Dyslipidemias / Q000150:complications; D005060:Europe; D015444:Exercise; D005260:Female; D006176:Gynecology; D020249:Hormone Replacement Therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008659:Metabolic Diseases / Q000150:complications; D047648:Perimenopause; D012307:Risk Factors; D017678:Sex Distribution; D012907:Smoking / Q000009:adverse effects
D003276:Contraceptives, Oral